{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:38:56Z","timestamp":1792517936778,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Prostatic artery embolization (PAE) has emerged as a minimally invasive treatment for benign prostatic obstruction (BPO), offering clinically meaningful symptom improvement with a favorable perioperative safety and sexual function profile. This narrative review synthesizes the current evidence on PAE relative to transurethral resection of the prostate (TURP) and holmium laser enucleation (HoLEP), and other minimally invasive surgical treatments (MISTs). PAE generally offers a more favorable perioperative safety profile and shorter recovery time, at the cost of higher reintervention rates. PAE improves lower urinary tract symptoms, quality of life, and urinary flow; however, the magnitude of improvement is generally smaller than that observed in comparative studies with TURP and HoLEP. At the same time, PAE is consistently associated with fewer perioperative complications, shorter recovery time, and a significantly higher preservation of ejaculation function. Reintervention rates after PAE are significantly higher than those after TURP, reaching approximately one in five patients at 2 years and nearly half at 5 years in long-term randomized follow-up, suggesting limited long-term durability compared with resective surgery. This review summarizes current patient selection criteria, anatomic and technical considerations, embolization material choices, and clinical outcomes, and also presents comparative data with TURP, HoLEP, and GreenLight photoselective vaporization. Emerging technologies, including imaging guidance and AI-assisted planning, may further optimize patient selection and procedural consistency, but longer-term comparative trials and standardized protocols are needed. Overall, PAE offers an option for carefully selected patients who prioritize functional preservation or are at high surgical risk, with the added disadvantage of lower long-term durability compared to standard surgical approaches.<\/jats:p>","DOI":"10.3390\/jcm14248631","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:20:29Z","timestamp":1765210829000},"page":"8631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Promising Minimally Invasive Option Emerging in the Treatment of Benign Prostatic Obstruction: Prostatic Artery Embolization"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-0262","authenticated-orcid":false,"given":"Rasit","family":"Dinc","sequence":"first","affiliation":[{"name":"INVAMED Medical Innovation Institute, New York, NY 10007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1106637","article-title":"Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms","volume":"367","author":"Sarma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.eururo.2013.10.040","article-title":"180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial\u2014The GOLIATH study","volume":"65","author":"Bachmann","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","article-title":"Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms","volume":"84","author":"Gravas","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.urology.2023.11.014","article-title":"Incidental prostate cancer diagnosis is common after holmium laser enucleation of the prostate","volume":"183","author":"Sakai","year":"2023","journal-title":"Urology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023","volume":"211","author":"Sandhu","year":"2024","journal-title":"J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2021.02.008","article-title":"Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial","volume":"80","author":"Abt","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","article-title":"Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia","volume":"44","author":"Knight","year":"2020","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe","volume":"30","author":"Patel","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvir.2012.07.028","article-title":"Prostatic arterial supply: Anatomic and imaging findings relevant for selective arterial embolization","volume":"23","author":"Bilhim","year":"2012","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jvir.2013.10.026","article-title":"Human cadaveric specimen study of the prostatic arterial anatomy: \u0130mplications for arterial embolization","volume":"25","author":"Garategui","year":"2014","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jiang, Y.-L., and Qian, L.-J. (2019). Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: A meta-analysis. BMC Urol., 19.","DOI":"10.1186\/s12894-019-0440-1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4103\/0366-6999.161370","article-title":"Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results","volume":"128","author":"Li","year":"2015","journal-title":"Chin. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jvir.2019.11.013","article-title":"Effect of Median Lobe Enlargement on Early Prostatic Artery Embolization Outcomes","volume":"31","author":"Maron","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jvir.2019.02.013","article-title":"Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interven-tional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Soci\u00e9t\u00e9 Fran\u00e7aise de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Inter-ventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Inter-ventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Inter-ventional Radiology","volume":"30","author":"McWilliams","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"k2338","DOI":"10.1136\/bmj.k2338","article-title":"Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial","volume":"361","author":"Abt","year":"2018","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jvir.2019.12.810","article-title":"Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia","volume":"31","author":"Insausti","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1148\/rg.2021200144","article-title":"Prostatic Artery Embolization: Indications, Preparation, Techniques, Imaging Evaluation, Reporting, and Complications","volume":"41","author":"Dias","year":"2021","journal-title":"RadioGraphics"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Loffroy, R., Guillen, K., Salet, E., Marcelin, C., Comby, P.-O., Midulla, M., Grenier, N., Chevallier, O., and Petitpierre, F. (2021). Prostate Artery Embolization Using N-Butyl Cyanoacrylate Glue for Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Valid Alternative to Microparticles?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143161"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00270-019-02379-3","article-title":"CIRSE Standards of Practice on Prostatic Artery Embolisation","volume":"43","author":"Cornelis","year":"2019","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xhepa, G., Sciacqua, L.V., Vanzulli, A., Can\u00ec, A.E., Ascenti, V., Ricoeur, A., Ianniello, A.A., Inzerillo, A., Nicotera, P., and Del Grande, F. (2024). Prostate Artery Embolization (PAE) with Small Beads for the Treatment of Benign Prostatic Hyperplasia (BPH). J. Pers. Med., 14.","DOI":"10.3390\/jpm14060613"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Amouyal, G., Tournier, L., De Margerie-Mellon, C., Pachev, A., Assouline, J., Bouda, D., De Bazelaire, C., Marques, F., Le Strat, S., and Desgrandchamps, F. (2022). Safety Profile of Ambulatory Prostatic Artery Embolization after a Significant Learning Curve: Update on Adverse Events. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081261"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00270-022-03272-2","article-title":"Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","volume":"45","author":"Xu","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diii.2023.01.012","article-title":"Long-term outcomes of prostate artery embolization for acute urinary retention: An analysis of 88 patients","volume":"104","author":"Marchi","year":"2023","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jvir.2024.11.002","article-title":"Prostatic Artery Embolization: Mid- to Long-Term Outcomes in 1075 Patients","volume":"36","author":"Bhatia","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.euf.2024.03.001","article-title":"Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial","volume":"10","author":"Hechelhammer","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11812","DOI":"10.12998\/wjcc.v10.i32.11812","article-title":"Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and meta-analysis","volume":"10","author":"Wang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_28","unstructured":"Ghahfarokhi, H.M., Lluxshiny, S., Krishnika, V., Durga, J., and Amina, A. (2025, August 04). Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis of Sexual Function, Urinary Symptoms, Procedural Outcomes, and Quality of Life. The International Continence Society. Available online: https:\/\/www.ics-eus.org\/Abstracts\/Publish\/1292\/000646_poster_20250714_093111.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ini\u2019, C., Vasile, T., Foti, P.V., Timpanaro, C., Castiglione, D.G., Libra, F., Falsaperla, D., Tiralongo, F., Giurazza, F., and Mosconi, C. (2024). Prostate Artery Embolization as Minimally Invasive Treatment for Benign Prostatic Hyperplasia: An Updated Systematic Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092530"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1557988320923910","DOI":"10.1177\/1557988320923910","article-title":"Prostatic Artery Embolization for Benign Prostatic Hyperplasia Treatment: A Russian Multicenter Study in More Than 1000 Treated Patients","volume":"14","author":"Kamalov","year":"2020","journal-title":"Am. J. Men\u2019s Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s42155-023-00402-w","article-title":"Non-target embolic events during prostatic embolization with ethylene vinyl alcohol copolymer (EVOH)","volume":"6","author":"Arnoffi","year":"2023","journal-title":"CVIR Endovasc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.euf.2018.09.005","article-title":"Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis","volume":"5","author":"Zumstein","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2019.11.010","article-title":"Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia","volume":"77","author":"Pisco","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bju.14249","article-title":"Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: An observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)","volume":"122","author":"Ray","year":"2018","journal-title":"BJU Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prnil.2020.04.001","article-title":"Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia","volume":"8","author":"Radwan","year":"2020","journal-title":"Prostate Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00270-022-03199-8","article-title":"Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period","volume":"45","author":"Bilhim","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.jvir.2025.01.011","article-title":"Abstract no. lba3 A prospective, non-randomized, controlled investigation of PAE (PE) vs HoLEP (Ho) for the treatment of symptomatic benign prostatic hyperplasia in prostate glands larger than 80 g: The HoPE trial: 12-Month outcomes","volume":"36","author":"Bhatia","year":"2025","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prnil.2025.03.001","article-title":"Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results","volume":"13","author":"Lim","year":"2025","journal-title":"Prostate Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.acra.2024.12.025","article-title":"Long-term Efficacy of Prostatic Artery Embolization Alone Versus Prostatic Artery Embolization Followed by HoLEP for Large (>80 cm3) Benign Prostatic Hyperplasia","volume":"32","author":"Xu","year":"2024","journal-title":"Acad. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41391-023-00743-6","article-title":"Comparison of perioperative and short-terms outcomes of en-bloc Holmium laser enucleation of the prostate (HoLEP) and robot-assisted simple prostatectomy: A propensity-score matching analysis","volume":"27","author":"Grosso","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Moulin, B., Di Primio, M., Vignaux, O., Sarrazin, J.L., Angelopoulos, G., and Hakime, A. (2022). Prostate Artery Embolization: Challenges, Tips, Tricks, and Perspectives. J. Pers. Med., 13.","DOI":"10.3390\/jpm13010087"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Alowais, S.A., Alghamdi, S.S., Alsuhebany, N., Alqahtani, T., Alshaya, A.I., Almohareb, S.N., Aldairem, A., Alrashed, M., Bin Saleh, K., and Badreldin, H.A. (2023). Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Med. Educ., 23.","DOI":"10.1186\/s12909-023-04698-z"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/24\/8631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:46:53Z","timestamp":1765212413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/24\/8631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":42,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["jcm14248631"],"URL":"https:\/\/doi.org\/10.3390\/jcm14248631","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}